hydrocodone bitartrate

Modify Date: 2024-01-09 19:26:22

hydrocodone bitartrate Structure
hydrocodone bitartrate structure
Common Name hydrocodone bitartrate
CAS Number 34195-34-1 Molecular Weight 467.46600
Density N/A Boiling Point 461.4ºC at 760mmHg
Molecular Formula C22H29NO10 Melting Point 198ºC
MSDS N/A Flash Point 232.9ºC

 Names

Name hydrocodone bitartrate
Synonym More Synonyms

 Chemical & Physical Properties

Boiling Point 461.4ºC at 760mmHg
Melting Point 198ºC
Molecular Formula C22H29NO10
Molecular Weight 467.46600
Flash Point 232.9ºC
Exact Mass 467.17900
PSA 163.06000

 MSDS


Section 1. Chemical Product and Company Identification
Hydrocodone bitartrate
Common Name/
Trade Name
Manufacturer
Commercial Name(s)
Synonym
Chemical Name
Chemical Family
Hydrocodone bitartrate

Section 4. First Aid Measures
Eye ContactCheck for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water
for at least 15 minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin ContactWash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation
develops. Cold water may be used.
Serious Skin ContactNot available.
InhalationIf inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Get medical attention.
Serious InhalationNot available.
IngestionDo NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to
an unconscious person. If large quantities of this material are swallowed, call a physician immediately.
Loosen tight clothing such as a collar, tie, belt or waistband.
Serious IngestionNot available.

Section 5. Fire and Explosion Data
Flammability of the Product May be combustible at high temperature.
Auto-Ignition Temperature Not available.
Not available.
Flash Points
Flammable LimitsNot available.
Products of CombustionThese products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...).
Fire Hazards in Presence of Slightly flammable to flammable in presence of heat.
Various Substances
Risks of explosion of the product in presence of mechanical impact: Not available.
Explosion Hazards in
Risks of explosion of the product in presence of static discharge: Not available.
Presence of Various
Substances
SMALL FIRE: Use DRY chemical powder.
Fire Fighting Media
LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
and Instructions
Special Remarks onNot available.
Fire Hazards
Special Remarks on Explosion Not available.
Hazards

Section 6. Accidental Release Measures
Small SpillUse appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by
spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
Large SpillUse a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading
water on the contaminated surface and allow to evacuate through the sanitary system.

Section 7. Handling and Storage
Keep away from heat. Keep away from sources of ignition. Ground all equipment containing material. Do
Precautions
not ingest. Do not breathe dust. Wear suitable protective clothing. If ingested, seek medical advice
immediately and show the container or the label.
StorageKeep container tightly closed. Keep container in a cool, well-ventilated area. Sensitive to light. Store in
light-resistant containers.
Hydrocodone bitartrate

Section 8. Exposure Controls/Personal Protection
Engineering ControlsUse process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels
below recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep
exposure to airborne contaminants below the exposure limit.
Personal ProtectionSafety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be
a Large Spillused to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a
specialist BEFORE handling this product.
Exposure LimitsNot available.

Section 9. Physical and Chemical Properties
Physical state and appearance Solid. (Powdered solid. Crystalline powder.)OdorOdorless.
TasteNot available.
Molecular Weight394.5 g/mole
White.
Color
Not available.
pH (1% soln/water)
Boiling PointNot available.
146°C (294.8°F) - 148 C.
Melting Point
Critical TemperatureNot available.
Not available.
Specific Gravity
Vapor PressureNot applicable.
Vapor DensityNot available.
Not available.
Volatility
Odor ThresholdNot available.
Not available.
Water/Oil Dist. Coeff.
Ionicity (in Water)Not available.
Dispersion PropertiesSee solubility in water, methanol.
SolubilitySoluble in cold water.
Partially soluble in methanol.
Insoluble in diethyl ether.

Section 10. Stability and Reactivity Data
The product is stable.
Stability
Instability TemperatureNot available.
Excess heat, dust generation. light, incompatible materials
Conditions of Instability
Incompatibility with various Reactive with oxidizing agents, alkalis.
substances
Non-corrosive in presence of glass.
Corrosivity
Special Remarks onSensitive to light.
ReactivityIncompatible with heavy metal salts
Special Remarks onNot available.
Corrosivity
Will not occur.
Polymerization
Hydrocodone bitartrate

Section 11. Toxicological Information
Routes of EntryInhalation. Ingestion.
Toxicity to AnimalsHydrocodone Bitartrate (anhydrous CAS no. 143-71-5):
Acute oral toxicity (LD50): 375 mg/kg [Rat].
Chronic Effects on Humans May cause damage to the following organs: central nervous system (CNS).
Other Toxic Effects onHazardous in case of ingestion.
HumansSlightly hazardous in case of skin contact (irritant), of inhalation.
Special Remarks onNot available.
Toxicity to Animals
Special Remarks onMay cause adverse reproductive effects and birth defects (teratogenic).
Chronic Effects on Humans May affect genetic material (mutagenic)
Special Remarks on otherAcute Potential Health Effects:
Toxic Effects on HumansSkin: May cause skin irritation.
Eyes: May cause eye irritation.
Inhalation: May cause respiratory tract irritation.
Ingestion: Harmful if swallowed. May be habit forming. May cause nausea, vomiting, constipaton or
diarrhea, dry mouth, loss of appetite, sweating, flushing of the face, drop in body temperature, cold and
clammy skin. May affect respiration (respiratory depression, shortness of breath, trouble breathing),
behavior/central nervous system (analgesia, headache, dizziness, confusion, drowsiness, euphoria,
restlessness, nervousness, lightheadness, weakness, fainting, convulsions, unconciousness),
cardiovascular system (abnormal heartbeat, slow heartbeat, low blood pressure), blood (leukocytosis). May
cause blurred vision or double vision or pinpoint pupils, painful or decreased urination.

Section 12. Ecological Information
EcotoxicityNot available.
Not available.
BOD5 and COD
Products of BiodegradationPossibly hazardous short term degradation products are not likely. However, long term degradation
products may arise.
The products of degradation are less toxic than the product itself.
Toxicity of the Products
of Biodegradation
Special Remarks on theNot available.
Products of Biodegradation

Section 13. Disposal Considerations
Waste DisposalWaste must be disposed of in accordance with federal, state and local environmental
control regulations.

Section 14. Transport Information
DOT ClassificationNot a DOT controlled material (United States).
Not applicable.
Identification
Not applicable.
Special Provisions for
Transport
DOT (Pictograms)
Hydrocodone bitartrate

Section 15. Other Regulatory Information and Pictograms
No products were found.
Federal and State
Regulations
CaliforniaCalifornia prop. 65: This product contains the following ingredients for which the State of California has
Proposition 65found to cause cancer which would require a warning under the statute: No products were found.
Warnings
California prop. 65: This product contains the following ingredients for which the State of California has
found to cause birth defects which would require a warning under the statute: No products were found.
Other RegulationsOSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
EINECS: This product is not on the European Inventory of Existing Commercial Chemical Substances.
Canada: Not listed on Canadian Domestic Substance List (DSL) or Canadian Non- Domestic Substance
List (NDSL).
China: Not listed on National Inventory.
Japan: Not listed on National Inventory (ENCS).
Korea: Not listed on National Inventory (KECI).
Philippines: Not listed on National Inventory (PICCS).
Australia: Not listed on AICS.
WHMIS (Canada) CLASS D-2B: Material causing other toxic effects (TOXIC).
Other Classifications
DSCL (EEC)R22- Harmful if swallowed.S46- If swallowed, seek medical advice
immediately and show this container or label.
Health Hazard
HMIS (U.S.A.)2 National Fire Protection
1 Flammability
1 Association (U.S.A.)
Fire Hazard
2 0 Reactivity
Health
Reactivity
0
Specific hazard
Personal Protection
E
WHMIS (Canada)
(Pictograms)
DSCL (Europe)
(Pictograms)
TDG (Canada)
(Pictograms)
ADR (Europe)
(Pictograms)
Protective Equipment
Gloves.
Lab coat.
Dust respirator. Be sure to use an
approved/certified respirator or
equivalent. Wear appropriate respirator
when ventilation is inadequate.
Hydrocodone bitartrate


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QD2840000
CAS REGISTRY NUMBER :
34195-34-1
LAST UPDATED :
199504
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C18-H21-N-O3.C4-H6-O6
MOLECULAR WEIGHT :
449.50
WISWESSER LINE NOTATION :
T B6566 B6/CO 4ABBC R BX FV HO PN GHT&&TTJ JO1 P1 &OVYQYQVO

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
375 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 1,42,1959 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
153 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
REFERENCE :
AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 123,705,1975 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 80428 No. of Facilities: 2327 (estimated) No. of Industries: 3 No. of Occupations: 8 No. of Employees: 9115 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 80428 No. of Facilities: 162 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 2238 (estimated) No. of Female Employees: 1177 (estimated)

 Safety Information

RIDADR NONH for all modes of transport

 Synonyms

4,5-Epoxy-3-methoxy-17-methyl-morphinan-6-on,Hydrogentartrat
CODEINE IMP E
Codeine,10-hydroxy
4,5-Epoxy-3-methoxy-17-methyl-morphin-7-en-6,10-diol
Hydrocodone bitartrate salt hemi(pentahydrate)
4,5-epoxy-3-methoxy-17-methyl-morphinan-6-one,hydrogentartrate
HYDROCODONE BITARTRATE
7,8-DIDEHYDRO-4,5A-EPOXY-3-METHOXY-17-METHYLMORPHINAN-6A,10-DIOL